Albuterol inhaler    (DrugBank: Albuterol)

1 disease
IDDisease name (Link within this page)Number of trials
89Lymphangioleiomyomatosis1

89. Lymphangioleiomyomatosis    [ 38 clinical trials,   42 drugs,   (DrugBank: 19 drugs),   26 drug target genes,   134 drug target pathways]
Searched query = "Lymphangioleiomyomatosis", "LAM"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 38 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01799538
(ClinicalTrials.gov)
June 10, 201323/2/2013Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis13-H-0051 Bronchodilator Effects of Nebulized Versus Inhaled Albuterol in Subjects With LymphangioleiomyomatosisLymphangioleiomyomatosisDrug: albuterol inhaler;Drug: albuterol nebulizer;Procedure: PFTNational Heart, Lung, and Blood Institute (NHLBI)NULLRecruiting18 Years80 YearsFemale100Phase 2United States